SANOFI-AVENTIS (EPA:SAN) Press Release: Dupixent® (dupilumab) late-breaking data at AAD show significant improvements in signs and symptoms of moderate-to-severe atopic hand and foot dermatitis
Transparency directive : regulatory news
18/03/2023 15:00
SANOFI-AVENTIS's latest news
17/04/2024 07:00
12/04/2024 20:05
22/03/2024 07:30
15/03/2024 20:04
24/02/2024 15:51
23/02/2024 18:45
23/02/2024 07:00
22/02/2024 19:02
20/02/2024 23:40
15/02/2024 14:00
Other stories
26/04/2024 15:57
26/04/2024 13:45
26/04/2024 17:52
26/04/2024 15:02
26/04/2024 15:45
26/04/2024 14:26
26/04/2024 19:48
26/04/2024 15:57
26/04/2024 14:39
26/04/2024 18:59
Tories doomed at next election 'because of Boris Johnson and Liz Truss' – pollster - The Independent
26/04/2024 18:56
26/04/2024 20:00
26/04/2024 17:37
26/04/2024 13:29
26/04/2024 15:13
26/04/2024 14:07
26/04/2024 14:44
26/04/2024 16:56
26/04/2024 18:00
26/04/2024 16:48
26/04/2024 15:40
25/04/2024 18:17
26/04/2024 19:26
26/04/2024 17:45
26/04/2024 19:46
26/04/2024 11:59
26/04/2024 15:54
26/04/2024 09:00
26/04/2024 19:48
26/04/2024 15:05
26/04/2024 10:24
25/04/2024 19:30
25/04/2024 18:29
26/04/2024 17:56
26/04/2024 13:30
25/04/2024 23:17
26/04/2024 03:31
26/04/2024 12:00